CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cells.

导出 OA

翻译打印收藏纠错

第一作者： Marion,Alcantara

第一单位： Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker-Enfants Malades, Paris, France.

作者： Marion,Alcantara ^[1] ; Melania,Tesio ^[2] ; Carl H,June ^[2] ; Roch,Houot ^[3]

作者单位： Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker-Enfants Malades, Paris, France. ^[1] Institut Necker Enfants Malades (INEM), Institut National de Recherche Médicale (INSERM) U1151, Paris, France. ^[2] Center for Cellular Immunotherapies, Perlman School of Medicine, Philadelphia, PA, USA. ^[3] Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA. ^[4] Department of Pathology and Laboratory Medicine, Perlman School of Medicine, Philadelphia, PA, USA. ^[5] CHU Rennes, Service Hématologie Clinique, 35033, Rennes, France. roch.houot@chu-rennes.fr. ^[6] INSERM, U1236, 35043, Rennes, France. roch.houot@chu-rennes.fr. ^[7] INSERM 0203, Unité d'Investigation Clinique, 35033, Rennes, France. roch.houot@chu-rennes.fr. ^[8]